Patents

US 8399185 B2: Regulators of NFAT

Granted
2013-03-19
Filed
2007-01-05 application 12160030
Type
Utility · 9 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed are methods of identifying an agent that modulates an NFAT regulator protein. One such method comprises contacting at least one test agent with a recombinant cell comprising at least one NFAT regulator protein or fragment or derivative thereof, assessing the effect of the test agent on an activity, interaction, expression, or binding to the NFAT regulator protein or fragment or derivative thereof, and identifying the test agent that has an effect on an activity, interaction, expression, or binding to the NFAT regulator protein or fragment or derivative thereof, whereby the identified test agent is characterized as an agent that modulates an NFAT regulator protein. Methods of identifying an agent that modulates intracellular calcium, methods to screen for an agent that modulates NFAT regulator function, methods to diagnose unexplained immunodeficiency in a subject, and methods for identifying an agent for treating or preventing a disease or disorder associated with a NFAT regulator protein or calcium signaling are also disclosed.

Source: PVGPATDIS, file of 2026-04-10 (ipg130319.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Immune Disease Institute 8 patentsUS company or organizationBoston, MAImmune Disease Institute Inc Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Anjana RaoCambridge, MA32PVGPATDIS, file of 2026-04-10
Stefan FeskeNew York, NY3PVGPATDIS, file of 2026-04-10
Patrick HoganCambridge, MA8PVGPATDIS, file of 2026-04-10
Yousang GwackLos Angeles, CA3PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/4702PVGPATDIS, file of 2026-04-10
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N33/5041PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K35/12PVGPATDIS, file of 2026-04-10
C07HSugars; derivatives thereof; nucleosides; nucleotides; nucleic acidsC07H21/04PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/16PVGPATDIS, file of 2026-04-10
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processesC12Q1/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2013-08-16Assignment
Assignment of assignor's interest
THE CHILDREN'S HOSPITAL CORPORATION signed 2013-08-08CHILDREN'S MEDICAL CENTER CORPORATION BOSTON, MA31024/968ECORSEXC, file of 2026-09-25
2013-08-16Merger
Merger
IMMUNE DISEASE INSTITUTE, INC. signed 2012-10-01THE CHILDREN'S HOSPITAL CORPORATION BOSTON, MA31024/933ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.